MarketInOut Stock Screener Log In | Sign Up

Takeda Pharmaceutical Co Ltd

OTC • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Takeda Pharmaceutical Co Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeOTC
Market Capitalization67,093 mln
Float1,582 mln
Earnings Date10/29/2026

EPS

0.14
Overpriced

P / E

300
Bubble territory

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.48
Borderline

Relative Strength

95 / 100
Top performer

Debt / Equity

0.62
Moderate leverage

Business Description

Takeda Pharmaceutical Company is a Japanese drugmaker founded in 1781 and headquartered in Tokyo, with operations spanning North America, Europe, Asia, and beyond. The company discovers, develops, and sells medicines across several major health areas, including digestive diseases, rare conditions, cancer, vaccines, and brain health. Takeda markets a broad portfolio of well-known treatments and works alongside dozens of partner companies worldwide to bring new therapies to patients.

Key Fundamentals

EPS0.14
P/E300
ROE0.54
RPS19.06
ROIC4.58
ROA0.26
Interest Cover2.86
EBITDA, mln6,183
EV / EBITDA15.30
EV / EBIT51.09
Revenue, mln29,820
EV / Revenue3.17

Quote Details

Last 42.0000
Change 4.63 (12.39%)
Open 42.0000
Volume 150
Turnover 6,300
Average Volume 3,016.81

Financial Ratios

Pre-Tax Profit Margin-0
Leverage Ratio2.06
Current Ratio1.15
Price / Book1.43
Price / Cash Flow13.42
Price / Free Cash Flow18.53
Debt / Equity0.62
Price / Sales2.27
PEG Ratio0.47

Financial Strength

Altman Z-Score1.29
Piotroski F-Score 7 / 9
Beneish M-Score-2.48
Price to Intrinsic Value0.81
Shiller PE Ratio46.20

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.53% 86 / 100   
1 Month 22.74% 95 / 100   
2 Months 13.36% 83 / 100   
6 Months 53.44% 93 / 100   
1 Year 63.81% 87 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog